Outbreaks of infectious diseases have been recorded throughout history. Currently, SARS-CoV-2, a contagious virus that causes the disease called COVID-19, is impacting individuals worldwide. Many countries have set their sight on an effective vaccination program to end their infectious disease outbreaks. The term “herd immunity” has been mentioned in association with ending the COVID-19 outbreaks.
Now that the first COVID-19 vaccines are being rolled out, Operation Warp Speed, the FDA, and the CDC have recommended that governors proceed first with vaccinating two groups: healthcare workers and residents in nursing homes. But what about after that? Planning has started in all the states and territories regarding who will get the vaccine
National Institutes of Health Director Dr. Francis Collins told CNBC that “it was very likely” that the U.S. government is close to a deal with Pfizer for up to an additional 100 million Covid vaccine doses. “It is good news it sounds like it’s very likely,” said Collins. “We’ll have 400 million doses between Pfizer
As the coronavirus disease (COVID-19) threatens the globe infecting over 43.8 million people, the development of a vaccine against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is of paramount importance. Apart from the dissemination of the vaccine, its acceptance among the public is also crucial. Obtaining a high uptake of the vaccine will be